NRP-18552-08561
2 vaccinations
5 coded responses
22 check-ins
5 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 660 / KS
- Registered
- 2022-07-14
- Relationship
- Child or adolescent in my care
- Guardian
- X3S-10681-92716
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-14
Registered in v-safe
-
2022-07-14
Dose 1 — Moderna
-
2022-07-14
Survey response — day 0, dose 1, under 3MedDRA: Injection site rash — Feeling: Good · Site: Redness, Swelling/hardness · Rash, not including the immediate area around the injection siteFree text: The rash is about 1" diameter around the injection siteMedDRA releases: 2024-11 · check-in free text available
- 2022-07-15
-
2022-07-16
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Sleepiness, Irritability/crying, Loss of appetiteUnder 3 check-in
- 2022-07-17
-
2022-07-18
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
- 2022-07-19
- 2022-07-20
- 2022-07-21
-
2022-07-28
Survey response — day 14, dose 1, under 3MedDRA: Decreased appetite, Fatigue, Irritability, Nasopharyngitis, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to work or attend schoolFree text: (b)(6) currently has a bad head cold. Runny nose, sneezing, lack of appetite, and fussiness/fatigue.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-04
Survey response — day 21, dose 1, under 3MedDRA: Nasopharyngitis, Respiratory tract congestion — Feeling: FairFree text: (b)(6) coming down with another cold. He's stuffy and congested.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-11
Dose 2 — Moderna
-
2022-08-13
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Sleepiness, Irritability/crying, Loss of appetiteUnder 3 check-in
-
2022-08-14
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Sleepiness, Irritability/crying, Loss of appetiteUnder 3 check-in
-
2022-08-15
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Sleepiness, Irritability/crying, Loss of appetiteUnder 3 check-in
-
2022-08-16
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Sleepiness, Irritability/cryingUnder 3 check-in
-
2022-08-17
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Sleepiness, Irritability/crying, Loss of appetiteUnder 3 check-in
-
2022-08-18
Health check-in — day 7, dose 2, under 3Feeling: Fair · Sleepiness, Irritability/crying, Loss of appetiteUnder 3 check-in
- 2022-08-27
- 2022-09-01
-
2022-09-08
Survey response — day 28, dose 2, under 3MedDRA: Nasopharyngitis — Feeling: FairFree text: He has a head coldMedDRA releases: 2024-11 · check-in free text available
- 2022-09-22
-
2022-11-11
Survey response — 3 months, dose 2, under 3MedDRA: Asthma, Cough, Ear infection, Nasopharyngitis, Rhinorrhoea — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: (b)(6) has been struggling with a bad cold and an ear infection. Coughing, running nose, increase asthma attacks.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-11
Report sent to call center — 3 months, dose 2, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-11-14
-
2022-11-14
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-02-09
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-14 | Moderna | No |
| 2 | 2022-08-11 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-11 | Successful 2022-11-14 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 12 (Under 3) — day 0, dose 1, under 3
Systemic reaction (other): The rash is about 1" diameter around the injection site
Release 12 (Under 3) — day 14, dose 1, under 3
Symptoms: (b)(6) currently has a bad head cold. Runny nose, sneezing, lack of appetite, and fussiness/fatigue.
redacted (b)(6)
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: (b)(6) coming down with another cold. He's stuffy and congested.
redacted (b)(6)
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: He has a head cold
Release 12 (Under 3) — 3 months, dose 2, under 3
Symptoms: (b)(6) has been struggling with a bad cold and an ear infection. Coughing, running nose, increase asthma attacks.
redacted (b)(6)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Decreased appetite | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Irritability | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Injection site rash | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release